|
Turner, Corey W; Lima, Maria F; Villalta, Fernando (2002) Trypanosoma cruzi uses a 45-kDa mucin for adhesion to mammalian cells. Biochem Biophys Res Commun 290:29-34
|
|
Villalta, F; Smith, C M; Ruiz-Ruano, A et al. (2001) A ligand that Trypanosoma cruzi uses to bind to mammalian cells to initiate infection. FEBS Lett 505:383-8
|
|
Moody, T N; Ochieng, J; Villalta, F (2000) Novel mechanism that Trypanosoma cruzi uses to adhere to the extracellular matrix mediated by human galectin-3. FEBS Lett 470:305-8
|
|
Villalta, F; Zhang, Y; Bibb, K E et al. (1998) Signal transduction in human macrophages by gp83 ligand of Trypanosoma cruzi: trypomastigote gp83 ligand up-regulates trypanosome entry through the MAP kinase pathway. Biochem Biophys Res Commun 249:247-52
|
|
Villalta, F; Zhang, Y; Bibb, K E et al. (1998) The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide. Infect Immun 66:4690-5
|
|
Lima, M F; Zhang, Y; Villalta, F (1997) Beta-chemokines that inhibit HIV-1 infection of human macrophages stimulate uptake and promote destruction of Trypanosoma cruzi by human macrophages. Cell Mol Biol (Noisy-le-grand) 43:1067-76
|
|
Villalta, F; Smith, C M; Burns Jr, J M et al. (1996) Fab' fragments of a mAb to a member of family 2 of trans-sialidases of Trypanosoma cruzi block trypanosome invasion of host cells and neutralize infection by passive immunization. Ann N Y Acad Sci 797:242-5
|
